Key Questions Answered
Q: What did researchers discover about the serotonin 5-HT1A receptor?
A: They mapped how it activates different brain signaling pathways, offering insight into how mood and emotion are regulated at the molecular level.
Q: Why does this matter for antidepressants and antipsychotics?
A: Understanding this receptor’s precise behavior can help design faster-acting and more targeted treatments with fewer side effects.
Q: What surprising element plays a key role in receptor function?
A: A phospholipid — a fat molecule in cell membranes — acts like a co-pilot, helping steer how the receptor behaves, a first-of-its-kind discovery.
Summary: Scientists have uncovered how the brain’s 5-HT1A serotonin receptor—vital in mood regulation—functions at the molecular level. This receptor, a common target of antidepressants and psychedelics, prefers certain signaling pathways no matter the drug, but drugs can still vary in how strongly they activate them.
The study also identified a surprising helper: a phospholipid molecule that subtly guides receptor behavior. These findings could lead to more precise treatments for depression, anxiety, and psychosis.
Key Facts
- Biased Signaling: 5-HT1A favors certain pathways, regardless of drug.
- Lipid Influence: A membrane fat molecule helps control receptor activity.
- Drug Design Insight: Findings open door to more targeted psychiatric therapies.
Source: Mount Sinai Hospital
In a discovery that could guide the development of next-generation antidepressants and antipsychotic medications, researchers at the Icahn School of Medicine at Mount Sinai have developed new insights into how a critical brain receptor works at the molecular level and why that matters for mental health treatments.
The study, published in the August 1 online issue of Science Advances, focuses on the 5-HT1A serotonin receptor, a major player in regulating mood and a common target of both traditional antidepressants and newer therapies such as psychedelics.
Despite its clinical importance, this receptor has remained poorly understood, with many of its molecular and pharmacological properties largely understudied—until now.
“This receptor is like a control panel that helps manage how brain cells respond to serotonin, a key chemical involved in mood, emotion, and cognition,” says senior author Daniel Wacker, PhD, Assistant Professor of Pharmacological Sciences, and Neuroscience, at the Icahn School of Medicine at Mount Sinai.
“Our findings shed light on how that control panel operates—what switches it flips, how it fine-tunes signals, and where its limits lie. This deeper understanding could help us design better therapies for mental health conditions like depression, anxiety, and schizophrenia.”
Using innovative lab techniques, the research team discovered that the 5-HT1A receptor is inherently wired to favor certain cellular signaling pathways over others—regardless of the drug used to target it.
However, drugs can still influence the strength with which those pathways are activated. For example, the antipsychotic asenapine (brand name Saphris) was found to selectively engage a specific signaling route due to its relatively weak activity at the receptor.
To explore these mechanisms in greater detail, the researchers combined experiments in lab-grown cells with high-resolution cryo-electron microscopy—a cutting-edge imaging technology that reveals molecular structures at near-atomic resolution. Their work focused on how various drugs activate the 5-HT1A receptor and how the receptor interacts with internal signaling proteins known as G proteins.
Different signaling pathways controlled by the 5-HT1A receptor are linked to different aspects of mood, perception, and even pain. As scientists better understand which pathways are activated, and how, they can more precisely design drugs that treat specific symptoms or conditions without unwanted side effects.
“Our work provides a molecular map of how different drugs ‘push buttons’ on this receptor—activating or silencing specific pathways that influence brain function,” says study first author Audrey L. Warren, PhD, a former student in Dr. Wacker’s lab who is now a postdoctoral researcher at Columbia University.
“By understanding exactly how these drugs interact with the receptor, we can start to predict which approaches might lead to more effective or targeted treatments and which ones are unlikely to work. It’s a step toward designing next-generation therapies with greater precision and fewer side effects.”
In a particularly surprising finding, the researchers discovered that a phospholipid—a type of fat molecule found in cell membranes—plays a major role in steering the receptor’s activity, almost like a hidden co-pilot. This is the first time such a role has been observed among the more than 700 known receptors of this type in the human body.
While current antidepressants often take weeks to work, scientists hope this new understanding of 5-HT1A signaling could help explain those delays and lead to faster-acting alternatives.
“This receptor may help explain why standard antidepressants take long to work,” says Dr. Wacker.
“By understanding how it functions at a molecular level, we have a clearer path to designing faster, more effective treatments, not just for depression, but also for conditions like psychosis and chronic pain. It’s a key piece of the puzzle.”
Next, the research team plans to dig deeper into the role of the phospholipid “co-factor” and to test how their lab-based findings hold up in more complex experiments. They’re also working on turning these discoveries into real-world compounds that could become future psychiatric medications, building on their earlier success with drug candidates derived from psychedelics.
The paper is titled “Structural determinants of G protein subtype selectivity at the serotonin receptor 5-HT1A.”
The study’s authors, as listed in the journal, are Audrey L. Warren, Gregory Zilberg, Anwar Abbassi, Alejandro Abraham, Shifan Yang, and Daniel Wacker.
Funding: This work was supported by NIH grant GM133504. Further support came from NIH T32 Training Grant GM062754 and DA053558 and NIH F31 fellowship MH132317.
News
New COVID variant ‘Stratus’ is spreading in the U.S. and worldwide
A new COVID variant is climbing the ranks in the U.S., becoming the third-most common strain of the summer. Variant XFG, colloquially known as "Stratus," was first detected in Southeast Asia in January but [...]
Fat Molecule May Control How You Feel Emotion
Key Questions Answered Q: What did researchers discover about the serotonin 5-HT1A receptor? A: They mapped how it activates different brain signaling pathways, offering insight into how mood and emotion are regulated at the [...]
Nanodevice uses sound to sculpt light, paving the way for better displays and imaging
Light can behave in very unexpected ways when you squeeze it into small spaces. In a paper in the journal Science, Mark Brongersma, a professor of materials science [...]
ChatGPT helps speed up patient screening for clinical trials
A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers at UT Southwestern Medical Centre used [...]
New Study Reveals This Popular Fruit Is Actually a “Superfood”
A new peer-reviewed article argues that grapes deserve a place among today’s top superfoods. A recent article published in the peer-reviewed Journal of Agriculture and Food Chemistry takes a closer look at the term [...]
Experimental Drug Reverses PTSD Symptoms in Mice – Already in Human Trials
Excessive levels of GABA released by astrocytes impair the brain’s ability to extinguish fear responses in PTSD, but a newly identified drug target offers promising hope for treatment. Many people with post-traumatic stress disorder (PTSD) [...]
New high-selectivity nanozyme enables rapid and visible disease diagnostics
To enable early diagnosis of acute illnesses and effective management of chronic conditions, point-of-care testing (POCT) technology—diagnostics conducted near the patient—is drawing global attention. The key to POCT lies in enzymes that recognize and [...]
Globally, over 2.5 million COVID deaths prevented worldwide thanks to vaccines
Thanks to vaccinations against SARS-CoV-2 in the period 2020–2024, 2.533 million deaths were prevented at the global level; one death was avoided for every 5,400 doses of vaccine administered. Some 82% of the lives [...]
RNA-seq outperforms DNA methods in detecting actionable cancer mutations
Hospital for Sick Children in Toronto researchers are reporting that targeted RNA sequencing can detect clinically actionable alterations in 87% of tumors and provide decisive findings where DNA-seq either fails, returns no variant, or [...]
Physicists discover new state of quantum matter
Researchers at the University of California, Irvine have discovered a new state of quantum matter. The state exists within a material that the team reports could lead to a new era of self-charging computers [...]
Researchers create safer nonstick surface, cutting use of ‘forever chemicals’
A new material developed by researchers from University of Toronto Engineering could offer a safer alternative to the nonstick chemicals commonly used in cookware and other applications. The new substance repels both water and [...]
New research identifies critical gene for treatment
Amyotrophic lateral sclerosis (ALS) - which you may know as the disease that affected Stephen Hawking - is a fatal neurodegenerative disease that causes progressive muscle weakness. A research team at Tohoku University and [...]
DNA Nanoflower Targets Breast Cancer Cells in Drug Delivery Breakthrough
Scientists have developed a DNA nanoflower that delivers chemotherapy and gene therapy directly to breast cancer cells, boosting effectiveness while reducing side effects in early tests. Breast cancer continues to be one of the most [...]
New method genetically blocks mosquitoes from transmitting malaria
Mosquitoes kill more people each year than any other animal. In 2023, the blood-sucking insects infected a reported 263 million people with malaria, leading to nearly 600,000 deaths, 80% of which were children. Recent [...]
How Covid led to an ‘acceleration’ in brain ageing (even if you didn’t have the virus)
The Covid pandemic 'significantly' accelerated brain ageing – even among those who were never infected, a study suggests. Scientists say the strain on people's lives, from isolation for weeks on end to the uncertainty surrounding [...]
Novel Sonication Method Creates Realistic Nanoplastics for Pollution Research
Scientists have developed a simple sonication method to create nanoplastics that closely mimic environmental particles, promising more realistic studies of their ecological impact. Plastics like polyethylene, PET, and polystyrene are used worldwide. Through wear [...]
